Updates are available Correction dated 2021-06-07
Click to view Correction: https://doi.org/10.1186/s12936-021-03751-w
-
Authors
,
Agyapong, Prince Darko
Akite, Elaine Jacqueline
Ansah, Nana Akosua
Ansah, Patrick Odum
Asante, Kwaku Poku
Awuni, Denis Azabra
Azongo, Daniel K.
Boahen, Owusu
Bozonnat, Marie-Cecile
Copeland, Nathanial K.
Guerra Mendoza, Yolanda
Haine, Valerie
Harrison, Samuel Bernard Ekow
Kaali, Seyram
Kaburise, Michael Bandasua
Oduro, Abraham
Oguk, Esther
Otieno, Lucas
Otieno, Walter
Owusu-Agyei, Seth
Oyieko, Janet
Pirçon, Jean-Yves
Praet, Nicolas
Roman, François
Schuerman, Lode
Sing’oei, Valentine
Tivura, Mathilda
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA and PATH
- License Information
-
More Information
Article History
Received: 6 August 2020
Accepted: 25 February 2021
First Online: 26 April 2021
Change Date: 12 May 2021
Change Type: Update
Change Details: Following publication of the article, the affiliation details of the article have been corrected; see the correction linked to this article for further details.
Change Date: 8 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12936-021-03751-w
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, International Conference on Harmonization Guideline for Good Clinical Practice and Good Epidemiological Practice, and with the approval of the ethical review boards (Additional file ). Subjects’ whose parent(s)/legal representative provided written informed consent.
: Not applicable.
: EJA and VH are employed by the GSK group of companies. YGM, J-YP, FR and LS are employed by the GSK group of companies and hold shares in the GSK group of companies. NP was employed by the GSK group of companies at the time of the work and hold shares in the GSK group of companies. NP is now employed by Janssen Pharmaceutica NV, Beerse, Belgium. M-CB is employed by 4Clinics on behalf of the GSK group of companies. DAA, DKA, PDA, NAA, POA, KPA, OB, NKC, SBEH, SK, MBK, AO, EO, LO, WO, SO-A, JO, VS, MT, via their institutions, received grants from the GSK group of companies for the conduct of this study/work and for the conduct of studies outside the submitted work.
